Given the central role of VEGF in retinopathy and the ANG2-mediated context-dependent antagonism of TIE2 (exacerbating vascular disease), targeting both ligands could potentially provide additional benefits in vascular retinal disease.28 This evidence concerns the gene ANGPT2 and retinal disorder.